Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell...
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Peripheral T cell lymphoma (PTCL) represents a group of heterogeneous hematological malignancies, which are notoriously challenging to treat and outcomes are typically poor. Over the past two decades, clinical prognostic indices for patient risk stratification have evolved, while several targeted agents are now available to complement combination c...
Alternative Titles
Full title
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d6efa0be3e304d7aaf6ed861f63b9ad8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6efa0be3e304d7aaf6ed861f63b9ad8
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/s13045-024-01560-7
